A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications
NCT07012317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-01-08
Summary
The objective of this study is to assess self-reported gastrointestinal (GI) responses to three snack bars containing fiber/fiber blends vs. a control snack bar for 7 days each in adults using GLP-1 agonists.
Conditions
- Gastrointestinal Symptoms
- Weight Loss
- GLP-1
Interventions
- OTHER
-
High Fiber Bar with Inulin
Bar with Inulin - high fiber
- OTHER
-
High Fiber bar with Fiber Blend
Bar with a fiber blend of psyllium husk and bran fibers - high fiber
- OTHER
-
High Fiber Bar with Resistant Starch type 4
Bar with Resistant Starch type 4 - High Fiber
- OTHER
-
Low Fiber Bar
Snack Bar - Low Fiber
Sponsors & Collaborators
-
General Mills
collaborator INDUSTRY -
Midwest Center for Metabolic and Cardiovascular Research
lead OTHER
Principal Investigators
-
Kevin C Maki, PhD · MB Clinical Research and Consulting LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-29
- Primary Completion
- 2025-11-24
- Completion
- 2025-11-24
Countries
- United States
Study Locations
More Related Trials
-
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
NCT00483171 ·Status: TERMINATED ·Phase: PHASE3
-
A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
NCT06703021 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions
NCT06867718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
NCT06478563 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
NCT00479492 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
NCT00494767 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
NCT05129891 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus
NCT06615700 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
NCT00959426 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
NCT06801015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
GV101 in Healthy Obese Participants
NCT06979505 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
NCT07205900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
NCT03100058 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
NCT04081337 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption
NCT04926051 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
NCT05677867 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
NCT02958085 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
NCT02529631 ·Status: COMPLETED ·Phase: NA
-
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
NCT06579092 ·Status: COMPLETED ·Phase: PHASE2